Creo Medical Group PLC (AIM:CREO)
14.60
-0.15 (-1.02%)
Jul 7, 2026, 4:26 PM GMT
Creo Medical Group Market Cap
Creo Medical Group has a market cap or net worth of 65.13 million as of July 7, 2026. Its market cap has increased by 19.86% in one year.
Market Cap
65.13M
Enterprise Value
56.83M
Revenue
6.00M
Ranking
n/a
PE Ratio
12.29
Stock Price
14.60
Market Cap Chart
Since December 9, 2016, Creo Medical Group's market cap has increased from 64.46M to 65.13M, an increase of 1.04%. That is a compound annual growth rate of 0.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 65.13M | 63.45% |
| Dec 31, 2025 | 39.84M | -49.19% |
| Dec 31, 2024 | 78.42M | -51.05% |
| Dec 29, 2023 | 160.20M | 255.34% |
| Dec 30, 2022 | 45.08M | -83.01% |
| Dec 31, 2021 | 265.37M | -13.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 224.21B |
| GSK plc | 80.29B |
| Haleon | 32.12B |
| Smith & Nephew | 9.56B |
| 4basebio | 81.58M |
| Venture Life Group | 81.02M |
| Ondine Biomedical | 77.41M |
| AOTI, Inc. | 66.47M |